New appointment for Pfizer's Specialty Care Business Unit
This article was originally published in Scrip
Executive Summary
Pfizer has appointed Dr Yvonne Greenstreet senior vice-president and head of medicines development for the Specialty Care Business Unit. She takes over from Dr Michael Berelowitz, who is retiring. Dr Greenstreet joins after an 18-year career with GlaxoSmithKline, where she most recently was senior vice-president and chief of strategy, R&D.